These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 973880)

  • 1. Effects remaining after withdrawal of long-term beta-receptor blockade. Reduced heart rate and altered haemodynamic response to acute propranolol administration.
    Brundin T; Edhag O; Lundman T
    Br Heart J; 1976 Oct; 38(10):1065-72. PubMed ID: 973880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes induced by acute and prolonged administration of propranolol in systemic hemodynamics in hypertensive patients].
    Branzi A; Sanguinetti M; Ambrosioni E; Magnani B
    Boll Soc Ital Cardiol; 1970; 15(6):627-33. PubMed ID: 5517658
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic responses to exercise and acute beta-receptor blockade in renin sub-types of essential hypertension.
    Burkart F; Bühler FR; Pfisterer M; Lütold BE; Küng M
    Clin Sci Mol Med Suppl; 1976 Dec; 3():493s-496s. PubMed ID: 1071670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol.
    Shand DG
    Dis Mon; 1974 Oct; ():1-31. PubMed ID: 4606956
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemodynamic studies in hypertensive patients treated by oral proranolol.
    Prichard BN; Shinebourne E; Fleming J; Hamer J
    Br Heart J; 1970 Mar; 32(2):236-40. PubMed ID: 5440518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.
    Pietras RJ; Real MA; Poticha GS; Bronsky D; Waldstein SS
    Arch Intern Med; 1972 Mar; 129(3):426-9. PubMed ID: 4401571
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.
    Tarazi RC; Dustan HP
    Am J Cardiol; 1972 May; 29(5):633-40. PubMed ID: 5021493
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of propranolol.
    Nies AS; Shand DG
    Circulation; 1975 Jul; 52(1):6-15. PubMed ID: 1093761
    [No Abstract]   [Full Text] [Related]  

  • 11. Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.
    Hansson L; Zweifler AJ; Julius S; Ellis CN
    Int J Clin Pharmacol; 1974 Sep; 10(2):79-89. PubMed ID: 4448555
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect and hemodynamic changes during the use of Inderal].
    Miasnikov LA; Krasnikov IuA; Nikolaeva EN; Grigor'iants RA
    Kardiologiia; 1967 Oct; 7(10):67-72. PubMed ID: 5607201
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combination of beta-receptor blocking and vasodilator agent.
    Koch G
    Br Heart J; 1976 Dec; 38(12):1240-6. PubMed ID: 1008968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
    Zacest R; Gilmore E; Koch-Weser J
    N Engl J Med; 1972 Mar; 286(12):617-22. PubMed ID: 4401216
    [No Abstract]   [Full Text] [Related]  

  • 17. Propranolol therapy in essential hypertension.
    Lydtin H; Kusus T; Daniel W; Schierl W; Ackenheil M; Kempter H; Lohmöller G; Niklas M; Walter I
    Am Heart J; 1972 May; 83(5):589-95. PubMed ID: 4554488
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral and intravenous propranolol during exercise.
    Sutton JR; Hughson RL; McDonald R; Powles P; Jones NL; Fitzgerald JD
    Clin Pharmacol Ther; 1977 Jun; 21(6):700-5. PubMed ID: 862308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.
    Majid PA; Meeran MK; Benaim ME; Sharma B; Taylor SH
    Br Heart J; 1974 Jun; 36(6):588-96. PubMed ID: 4850484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.